19
Novel FDA PMA & de novo 510k approvals
45
U.S. Commercial Product Launches
34
Level I Clinical Trials
26
Strategic Financings
28
Exits by IPO or M&A
VENSANA CAPITAL
CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠